EA200600070A1 - Инъецируемая галеновая форма флупиртина - Google Patents

Инъецируемая галеновая форма флупиртина

Info

Publication number
EA200600070A1
EA200600070A1 EA200600070A EA200600070A EA200600070A1 EA 200600070 A1 EA200600070 A1 EA 200600070A1 EA 200600070 A EA200600070 A EA 200600070A EA 200600070 A EA200600070 A EA 200600070A EA 200600070 A1 EA200600070 A1 EA 200600070A1
Authority
EA
Eurasian Patent Office
Prior art keywords
glape
flupirtin
injectable
pharmaceutical composition
containing flupirtine
Prior art date
Application number
EA200600070A
Other languages
English (en)
Other versions
EA008145B1 (ru
Inventor
Михель Пирот
Норберт Штанг
Руди Тома
Хеннинг Блуме
Original Assignee
Авд.Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авд.Фарма Гмбх Унд Ко. Кг filed Critical Авд.Фарма Гмбх Унд Ко. Кг
Publication of EA200600070A1 publication Critical patent/EA200600070A1/ru
Publication of EA008145B1 publication Critical patent/EA008145B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Изобретение относится к лиофилизату, содержащему флупиртин, его применению для получения фармацевтической композиции для парентерального введения, способу получения указанной фармацевтической композиции для парентерального введения, содержащей флупиртин, способу получения лиофилизата, содержащего флупиртин, и к фармацевтической композиции, содержащей флупиртин, полученной с помощью этого способа.
EA200600070A 2003-06-20 2004-06-16 Инъецируемая галеновая форма флупиртина EA008145B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10327674A DE10327674A1 (de) 2003-06-20 2003-06-20 Injizierbare Darreichungsform von Flupirtin
PCT/EP2004/006449 WO2004112754A1 (de) 2003-06-20 2004-06-16 Injizierbare darreichungsform von flupirtin

Publications (2)

Publication Number Publication Date
EA200600070A1 true EA200600070A1 (ru) 2006-06-30
EA008145B1 EA008145B1 (ru) 2007-04-27

Family

ID=33495162

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600070A EA008145B1 (ru) 2003-06-20 2004-06-16 Инъецируемая галеновая форма флупиртина

Country Status (18)

Country Link
US (1) US20060252804A1 (ru)
EP (2) EP1638532B1 (ru)
JP (1) JP4617303B2 (ru)
KR (1) KR20060025182A (ru)
CN (1) CN1838943A (ru)
AR (1) AR044831A1 (ru)
AT (2) ATE553085T1 (ru)
CA (1) CA2528899A1 (ru)
DE (2) DE10327674A1 (ru)
DK (1) DK1987819T3 (ru)
EA (1) EA008145B1 (ru)
ES (2) ES2322999T3 (ru)
PL (2) PL1987819T3 (ru)
PT (1) PT1987819E (ru)
RS (1) RS20050941A (ru)
TW (1) TWI343261B (ru)
UA (1) UA84155C2 (ru)
WO (1) WO2004112754A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592002B2 (en) * 2005-10-31 2009-09-22 Bioderm Research Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction
JP5283050B2 (ja) * 2005-02-07 2013-09-04 国立大学法人京都大学 繊維強化複合材料
EP2052723A4 (en) * 2006-08-14 2010-07-28 Eisai R&D Man Co Ltd STABLE LYOPHILIZED PREPARATION
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152168A2 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
WO2009152142A1 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Sulfonate salts of flupirtine
DE102010030053A1 (de) * 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3133519A1 (de) 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
IN172468B (ru) 1990-07-14 1993-08-14 Asta Medica Ag
DE9321574U1 (de) * 1992-03-11 2000-06-29 Asta Medica Ag Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
DE4319649A1 (de) 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE4327516A1 (de) 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
DE19541405A1 (de) 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
JP2781783B2 (ja) * 1996-07-30 1998-07-30 山形日本電気株式会社 半導体装置用パッケージ
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
DE10048969A1 (de) 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
US7695736B2 (en) * 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition

Also Published As

Publication number Publication date
EP1638532A1 (de) 2006-03-29
ES2388088T3 (es) 2012-10-08
EA008145B1 (ru) 2007-04-27
PL1987819T3 (pl) 2012-09-28
TW200509984A (en) 2005-03-16
ATE423549T1 (de) 2009-03-15
RS20050941A (en) 2007-09-21
DE10327674A1 (de) 2005-01-05
WO2004112754A1 (de) 2004-12-29
KR20060025182A (ko) 2006-03-20
PL1638532T3 (pl) 2009-07-31
PT1987819E (pt) 2012-07-06
JP4617303B2 (ja) 2011-01-26
US20060252804A1 (en) 2006-11-09
AR044831A1 (es) 2005-10-05
UA84155C2 (ru) 2008-09-25
ATE553085T1 (de) 2012-04-15
EP1987819A1 (de) 2008-11-05
JP2007506660A (ja) 2007-03-22
CA2528899A1 (en) 2004-12-29
EP1638532B1 (de) 2009-02-25
CN1838943A (zh) 2006-09-27
DK1987819T3 (da) 2012-07-16
ES2322999T3 (es) 2009-07-03
EP1987819B1 (de) 2012-04-11
TWI343261B (en) 2011-06-11
DE502004009045D1 (de) 2009-04-09

Similar Documents

Publication Publication Date Title
EA200801460A1 (ru) Рекомбинантные моновалентные антитела и способы их получения
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
CY1110541T1 (el) Φαρμακευτικα σκευασματα με βελτιωμενες φαρμακευτικες ιδιοτητες που περιεχουν βελτιωτικα γευσης
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
CY1108549T1 (el) Συνθετικες μεθοδοι για απλιδινη και νεα κατα του ογκου παραγωγα, μεθοδοι κατασκευης και χρησης αυτων
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1109011T1 (el) ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ βd ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΔΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
CY1108401T1 (el) Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
MX2007004376A (es) Composiciones de fosfolipido y farmaco anti inflamatorio no esteroide asociados, y metodos para prepararlos.
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
EA200600070A1 (ru) Инъецируемая галеновая форма флупиртина
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
MXPA05010613A (es) Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo.
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ KG RU